Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

NYSE:DNA   4:00:00 PM EDT
1.99
+0.01 (+0.50%)
7:58:07 PM EDT: $1.95 -0.04 (-2.01%)
Earnings Announcements

Ginkgo Bioworks Reports Third Quarter 2022 Financial Results

Published: 11/14/2022 21:53 GMT
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A (DNA) - Ginkgo Bioworks Reports Third Quarter 2022 Financial Results.
Q3 Revenue Fell 14 Percent to $66.0 Million.
End of Quarter Cash Balance of Over $1.3 Billion Provides Continued Financial Flexibility.
Ginkgo Further Revised Its Expectation for Total Revenue From $425 - $440 Million to $460 - $480 Million in 2022.
Qtrly Loss per Share $0.41.
Q3 2022 Total Revenue of $66 Million, Down From $78 Million in Comparable Prior Year Period.
Q3 Earnings per Share View $-0.30, Revenue View $60.4 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $88 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $86.41 Million
Next Quarter EPS Guidance is expected to be -$0.12

More details on our Analysts Page.